Characterization and Analysis of Dispersed Systems

Injectable Dispersed Systems: Formulation, Processing, and Performance

Volumn , Issue , 2005, Pages 77-123

  Jiao, Jim ^a   Burgess, Diane J ^b  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78651479491     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780849350610-7     Document Type: Chapter

References (79)

1. RandD Feature Stories. Particle Sizing Gets Serious. http://www.rdmag.com/features.
2. Florence AT, Attwood D. Physicochemical Principles of Pharmacy. 3rd ed. Hampshire: Macmillan Press, 1998.
3. Singh M, Ravin LJ. Parenteral emulsions as drug carrier systems. J Parenter Sci Technol 1986; 40(1):34-41.
4. Grimes G, Vermess M, Gallelli JF, Griton M, Chatterji DC. Formulation and evaluation of an ethiodized oil emulsion for intravenous hepatography. J Pharm Sci 1979; 68:52.
5. Tomazic-Jezic VJ, Merritt K, Umbreit TH. Significance of the type and the size of biomaterial particles on phagocytosis and tissue distribution. J Biomed Mater Res 2001; 55(4):523-529.
6. Burnham WR, Hansrani PK, Knott CE, Cook JA, Davis SS. Stability of a fat emulsion based intravenous feeding mixture. Int J Pharm 1983; 13:9.
7. Floyd AG. Top ten considerations in the development of parenteral emulsions. PSTT 1999; 2:134-143.
8. Collins-Gold LC, Lyons RT, Bartholow LC. Parenteral emulsions for drug delivery. Adv Drug Deliv Rev 1990; 5:189-208.
9. Laval-Jeantet AM, Laval-Jeantet M, Bergot C. Effect of particle size on the tissue distribution of iodized emulsified fat following intravenous administration. Invest Radiol 1982; 17:617.
10. Mikula RJ. Emulsion characterization. In: Emulsion in the Petroleum Industry. American Chemical Society, 1992.
11. Conn PW. Confocal microscopy. In: Methods in Enzymology. Vol. 307. San Diego, CA: Academic Press, 1999.
12. Hou W, Papadopoulos KD. W1/O/W2 and O1/W/O2 globules stabilized with Span 80 and Tween 80. Colloids Surf A 1997; 125:181-187.
13. Ficheux MF, Bonakder L, Leal-Calderon F, Bibette J. Some stability criteria for double emulsions. Langmuir 1998; 14:2702-2706.
14. McCrone WC, McCrone LB, Delly JG. Polarized Light Microscopy. McCrone Research Institute, 1997.
15. Davis SS, Burbage AS. Electron micrography of water-in-oilin- water emulsions. J Colloid Interface Sci 1977; 62(2):361-363.
16. Pike ER. The analysis of polydisperse scattering data. In:Chen SH, Chu B, Nossal R, eds. Scattering Techniques Applied to Supermolecular and Nonequilibrium Systems. New York: Plenum Press, 1981.
17. Grabowski E, Morrison I. Measurements of suspended particles by quasi-elastic light scattering. In: Dahneke B, ed. Particle Size Distributions from Analysis of Quasi-Elastic Light Scattering Data. New York: Wiley-Interscience, 1983.
18. Bakan DA, Longino MA, Weichert JP, Counsell RE. Physicochemical characterization of a synthetic lipid emulsion for hepatocyte-selective delivery of lipophilic compounds: application to polyiodinated triglycerides as contrast agents for computed tomography. J Pharm Sci 1996; 85(9):908-914.
19. HainesBA, MartinA. Interfacial properties ofpowderedmaterial:caking in liquid dispersions II. J Pharm Sci 1961; 50:753-756.
20. Matthews BA, Rhodes CT. Some studies of flocculation phenomena in pharmaceutical suspensions. J Pharm Sci 1968; 57:569-573.
21. Lian T, Ho RJ. Design and characterization of a novel lipid-DNA complex that resists serum-induced destabilization. J Pharm Sci 2003; 92(12):2373-2385.
22. Gref R, Domb A, Quellec P, Blunk T, Mller RH, Verbavatz JM, Langer R. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev 1995; 16:215-233.
23. Chauvierre C, Labarre D, Couvreur P, Vauthier C. Novel spolysaccharide-decorated poly(isobutyl cyanoacrylate) nanoparticles. Pharm Res 2003; 20(11):1786-1793.
24. Yang SC, Benita S. Enhanced absorption and drug targeting by positively charged submicron emulsions. Drug Dev Res 2000; 50:476-486.
25. Lee MJ, Lee MH, Shim CK. Inverse targeting of drugs to reticuloendothelial system-rich organs by lipid microemulsion emulsified with poloxamer-338. Int J Pharm 1995; 113:175-187.
26. Liu F, Liu D. Long circulating emulsions (oil-in-water) as carries for lipophilic drugs. Pharm Res 1995; 12:1060-1064.
27. Song YK, Liu DX, Maruyama K, Takizawa T. Antibody mediated lung targeting of long-circulating emulsions. PDA J Pharm Sci Technol 1996; 50:372-377.
28. Allen TM, Moase EH. Therapeutic opportunities for targeted liposomal drug delivery. Adv Drug Deliv Rev 1996; 21:117-133.
29. Martin A. Physical Pharmacy. 4th ed. Baltimore, MD: Williams and Wilkins.
30. Hiemenz PC. Principles of Colloid and Surface Chemistry. 2nd ed. New York: Marcel Dekker, 1986.
31. Skiba M, Fessi H, Puisieux F, Duchene D, Wouessidjewe D. Development of new colloidal drug carrier from chemically modified cyclodextrins: nanospheres, and influence of physicochemical and technological factors on particle size. Int J Pharm 1996; 129:113-121.
32. Bochot A, Fattal E, Grossiord JL, Puisieux F, Couvreur P. Characterization of a new ocular delivery system based on a dispersion of liposomes in a thermosensitive gel. Int J Pharm 1998; 162(1-2):119-127.
33. Elbaz E, Zeevi A, Klang S, Benita S. Positively charged submicron emulsions: a new type of colloidal drug carrier. Int J Pharm 1993; 96:R1-R6.
34. Klang SH, Signos CS, Benita S, Frucht-Pery J. Evaluation of a positively charged submicron emulsion of piroxicam on the rabbit corneum healing process following alkali burn. J Control Release 1999; 57:19-27.
35. Calvo P, Remuna-Lopez C, Vila-Jato JL, Alonso MJ. Development of positively charged colloidal drug carrier: chitosan- coated polyester nanocapsules and submicron-emulsions. Colloid Polym Sci 1997; 275:46-53.
36. Jumma M, Muller BW. Physicochemical properties of chitosan lipid emulsions and their stability during the autoclaving process. Int J Pharm 1999; 183:175-184.
37. Samama JP, Lee KM, Biellmann JF. Enzymes and microemulsions:activity and kinetic properties of liver alcohol dehydrogenase in ionic water-in-oil microemulsions. Eur J Biochem 1987; 163:609-617.
38. Hunter RJ. Zeta Potential in Colloid Science, Principles and Applications. London: Academic Press, 1981.
39. Alessandro M, Sara L. Sustained release injectable products. Am Pharm Rev 2003; 3 Apr Fall.
40. Rosenblatt J, Devereux B, Wallace DG. Effect of electrostatic forces on the dynamic rheological properties of injectable collagen biomaterials. Biomaterials 1992; 12(12):878-886.
41. Tipton AJ, Dunn RL. In situ gelling systems-sustained release injectable products. In: Senior J, Radomsky M, eds. Interpharm Press, 2000:241-278.
42. Ansel HC, Allen LV, Popovich NG. Pharmaceutical Dosage Forms and Drug Delivery Systems. 7th ed. Philadelphia, PA:Lippincott Williams and Wilkins, 1999.
43. Ramstack JM, Riley MG, Zale SE, Hotz JM, Johnson OL. Preparation of injectable suspensions having improved injectability. US Patent 57787520000525, 2000.
44. Kita Y, Matsumoto S, Yonezawa D. Viscometric method for estimating the stability of W/O/W type multiple-phase emulsions. J Colloid Interface Sci 1977; 62:87-94.
45. Matsumoto S, Kohda M. The viscosity of W/O/W emulsions:an attempt to estimate the water permeation coefficient of the oil layer from the viscosity changes in diluted system on aging under osmotic pressure gradient. J Colloid Interface Sci 1980; 73(1):13-20.
46. Burgess DJ. In: Pezzuto JM, Johnson ME, Manasse HR, eds. Biotechnology and Pharmacy. New York: Chapman and Hall, 1993:116.
47. Swarbrick J. Coarse dispersions. In: Gennaro AR, ed. Remington: The Science and Practice of Pharmacy, 1997.
48. Sheriff M, Warburton B. Measurement of dynamic rheological properties using the principle of externally shifted and restored resonance. Polymer 1974; 15:253-254.
49. Daemen T, Velinova M, Regts J, de Jager M, Kalicharan R, Donga J, van der Want JJL, Scherphof GL. Different intrahepatic distribution of phosphatidylglycerol and phosphatidylserine liposomes in the rat. Hepatology 2003; 26(2):416-423.
50. Kurihara A, Shibayama Y, Yasuno A, Ikeda M. Lipid emulsions of palmitoylrhizoxin: effects of particle size on blood disposition of emulsion lipid and incorporated compound in rats. Biopharm Drug Dispos 1996; 17(4):343-353.
51. Cannon JB, Martin C, Drummond GS, Kappas A. Targeted delivery of a heme oxygenase inhibitor with a lyophilized liposomal tin mesoporphyrin formulation. Pharm Res 1993; 10(5):715-721.
52. Cauchetier E, Fessi F, Boulard Y, Deniau M, Astier A, Paul M. Preparation and physicochemical characterization of atrovaquone- containing liposomes. Drug Dev Res 1999; 47(4):155-161.
53. Green TR, Fisher J, Matthews JB, Stone MH, Ingham E. Effect of size and dose on bone resorption activity of macrophages by in vitro clinically relevant ultra high molecular weight polyethylene particles. J Biomed Mater Res 2000; 53(5):490-497.
54. Cadee JA, Brouwer LA, den Otter W, Hennink WE, van Luyn MJA. A comparative biocompatibility study of microspheres based on crosslinked dextran or poly(lactic-co-glycolic)acid after subcutaneous injection in rats. J Biomed Mater Res 2001; 56(4):600-609.
55. Bremer C, Allkemper T, Baermig J, Reimer P. RES-specific imaging of the liver and spleen with iron oxide particles designed for blood pool MR-angiography. J Magn Reson Imaging 1999; 10(3):461-467.
56. Brotherton CM, Davis RH. Electroosmotic flow in channels with step changes in zeta potential and cross-section. J Colloid Interface Sci 2004; 270(1):242-246.
57. Burgess DJ, Yoon JK. Interfacial tension studies on surfactant systems at the aqueous/perfluorocarbon interface. Colloid Surf B 1993; 1:283-293.
58. Burgess DJ, Yoon JK. Influence of interfacial properties on perfluorocarbon/aqueous emulsion stability. Colloid Surf 1995; 4:297-308.
59. Burgess DJ, Sahin NO. Interfacial rheology of b-casein solution. In: Herb CA, Prud’homme RK, eds. Structure and Flow in Surfactant Solutions. ACS Symposium Series, 1994:380-393.
60. Burgess DJ, Sahin NO. Influence of protein emulsifier interfacial properties on oil-in-water emulsion stability. Pharm Dev Technol 1998; 3(1):21-29.
61. Chavany C, Saison-Behmoaras T, Le Doan T, Puisieux F, Couvreur P, Helene C. Adsorption of oligonucleotides onto polyisohexylcyanoacrylate nanoparticles protects them against nucleases and increases their cellular uptake. Pharm Res 1994; 11:1370-1378.
62. Couvreur P, Dubernet C, Puisieux F. Controlled drug delivery with nanoparticles: current possibilities and future trends. Eur J Pharm Biopharm 1995; 41:2-13.
63. De Chasteigner S, Fessi H, Devissaguet J-P, Puisieux F. Comparative study of the association of itraconazole with colloidal drug carriers. Drug Dev Res 1996; 38:125-133.
64. Jiao J, Burgess DJ. Ostwald ripening of water-in-hydrocarbon emulsions stabilized by non-ionic surfactant Span 83. J Colloid Interface Sci 2003; 264(2):509-516.
65. Jiao J, Burgess DJ. Rheology and stability of W/O/W multiple emulsions containing Span 83 and Tween 80. AAPS Pharm Sci 2003; 5(1), article 7 (http://www.aapspharmsci.org).
66. Jiao J, Rhodes DG, Burgess DJ. Multiple emulsion stability:pressure balance and interfacial film strength. J Colloid Interface Sci 2002; 250:444-450.
67. Lundberg B. Preparation of drug-carrier emulsions stabilized with phosphatidylcholine-surfactant mixtures. J Pharm Sci 1994; 83:72-75.
68. Lundberg B. A submicron lipid emulsion coated with amphipathic polyethylene glycol for parenteral administration of paclitaxel (Taxol). J Pharm Pharmacol 1997; 49:16-21.
69. Passirani C, Barratt G, Devissaguet J-P, Labarre D. Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system. Life Sci 1998; 62:775-785.
70. Passirani C, Barratt G, Devissaguet J-P, Labarre D. Longcirculating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate). Pharm Res 1998; 15(7):1046-1050.
71. Prankerd RJ, Stella VJ. The use of oil-in-water emulsions as a vehicle for parenteral drug administration. J Parenter Sci Technol 1990; 44:139-149.
72. Puisieux F, Barratt G, Benita S, Couarraze G, Couvreur P, Devissaguet J-Ph, Dubernet C, Fattal E, Fessi H, Vauthier C. Polymeric micro- and nanoparticles as drug carriers. In: Dumitru S, Szycher M, eds. Polymeric Materials for Biomedical Applications. New York: Marcel Dekker Inc., 1993:749-794.
73. Robert C, Malvy C, Couvreur P. Inhibition of the Friend retrovirus by antisense oligonucleotides encapsulated in liposomes:mechanism of action. Pharm Res 1993; 10:1427-1433.
74. Sheriff M, Warburton B. The theory of a universal oscillatory rheometer for the study of linear viscoelastic materials using the principle of normalized resonance. In: Theoretical Rheology. London: Applied Science Publishers, 1975:299-316.
75. Strickley RG, Anderson BD. Solubilization and stabilization of an anti-HIV thiocarbamate, NSC 629243, for parenteral delivery using extemporaneous emulsions. PDA J Pharm Sci Technol 1993; 10:1076-1082.
76. Tarr BD, Sambandan TG, Yalkowsky SH. A new parenteral emulsion for the administration of taxol. Pharm Res 1987; 4:162-165.
77. Vippagunta SR, Brittain HG, Grant DJW. Crystalline solids. Adv Drug Deliv Rev 2001; 48(1):3-26.
78. Wiersma PH, Loeb AL, Overbeek JTG. J Colloid Interface Sci 1966; 22:78.
79. Zhu H, Grant DJW. Dehydration behavior of nedocromil magnesium pentahydrate. Int J Pharm 2001; 215(1-2):251-262.